
1.65BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US67080M1036
CUSIP
67080M103
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
November
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
4.65
Dividend Share
-
Dividend Yield
-
Earnings Share
-3.17
Wall Street Target Price
30.24
EPS Estimate Current Year
-2.96
EPS Estimate Next Year
-2.85
EPS Estimate Current Quarter
-0.7646
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
71,779,000
Gross Profit TTM
-259,598,000
EBITDA
-307,311,008
Profit Margin
0.00%
Return On Assets TTM
-31.50%
Return On Equity TTM
-61.40%
Revenue Per Share TTM
0.769
Qtly Revenue Growth YOY
-66.10%
Diluted Eps TTM
-3.17
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
23.482
Price Book MRQ
3.505
Enterprise Value Revenue
16
Enterprise Value EBITDA
-3
101.17
2.78%334.09
2.62%315.00
1.67%342.56
0.98%24.77
0.65%833.78
0.60%444.45
0.05%712.02
0.00%159.38
-1.76%755.00
-0.07%